You searched for "blind"

4869 results found

Glaucoma-NET: a novel way of improving glaucoma management in sub-Saharan Africa

Background Glaucoma is the second most common cause of blindness worldwide [1]. People with untreated glaucoma suffer from irreversible, progressive loss of sight. The disease is characterised by progressive loss of visual field, with pathological cupping of the optic disc...

Making sense of the orthoptic assessment

Following the Specialty Trainee article on this topic in the February/March 2020 issue, Joe Smith provides a more detailed breakdown of the orthoptic report. Orthoptists investigate, diagnose and manage a wide variety of patients with varying problems. In this article,...

Risk factors and untreated POAG

The authors examined 50 untreated open angle glaucoma patients to determine if there was an association between the level of glaucomatous damage and documented risk factors. In this study the authors measured the extent of morphologic and functional glaucomatous damage...

New date confirmed for Plymouth dry eye event

Evening of education, innovation and networking rescheduled to 16 June. SightCare, the trusted partner to independent optical practices in the UK, is pleased to announce that its dry eye roadshow event in partnership with Lumenis will now take place on...

IN FOCUS - VISION 2020 LINKS Programme: the contribution of health partnerships to reduction in blindness worldwide

As other articles in this series (IN FOCUS Apr 2020) demonstrate, the year 2020 is highly significant in the eye care field. Naming a global initiative ‘VISION 2020: The Right to Sight’ in 1999 was a daring way to focus...

Haag-Streit UK launch a new e-shop

Haag-Streit UK is pleased to announce the launch of a brand new e-shop at https://eshopuk.haag-streit.com/

Impact of Eye Health Surveys and Partnerships in The Gambia

This article brings together the three national eye health surveys that have been undertaken in The Gambia between 1986 and 2019 and the impact that the results have had nationally and internationally. In it we describe the long-term capacity-strengthening for...

Assessing everyday visual function in dry AMD – what matters to the person?

Age-related macular degeneration (AMD) is the primary cause of blindness in the developed world and is accountable for more than one half of sight impairment registrations within England and Wales [1]. AMD is prevalent in people aged 60 years and...

Medical management and diabetic retinopathy progression

The ACCORD Eye Study was designed to evaluate the benefit of intensive glycaemic control (HbA1c <6.0% vs 7.0-7.9%), intensive systolic blood pressure control (<120mmHg vs. <140mmHg), and combined fenofibrate and simvastatin therapy in the development and progression of diabetic retinopathy....

Semaglutide and vision loss: A new concern for NAION risk?

This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...

HS-UK to be authorised distributor for the Vision Engineering 3D Deep Reality Viewer

HS-UK is delighted to announce that it is now the authorised distributor for the Deep Reality Viewer (DRV) in the UK.

Over 8700 Scots will lose their sight this year

New data from sight loss charity RNIB reveals that 8730 people in Scotland will begin living with sight loss in the next 12 months alone, and that the total number of people affected is set to grow by nearly 21%...